News | News By Subject | News by Disease News By Date | Search News

Get Our FREE
Industry eNewsletter


Biotechnology Headlines from PR Newswire

New Possibilities in the Fight Against Pancreatic Cancer
Relmada Therapeutics Announces Results of Annual Shareholders Meeting
ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series
U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023
New Chairman Appointed at Egenix, Inc.
Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023
Micro Market Monitor: Global Bio Stimulants in Turf and Ornamentals Market
Micro Market Monitor: Asia-Pacific Clinical Chemistry Market
23andMe Study Sketches Genetic Portrait of the United States
NorthStar Anesthesia Acquires AmSol, Expands Presence in Southeast and Midwest
ABIVAX, a Privileged Partner of the Cuban Life Science Industry, Welcomes Initiative to Renew Relations Between the USA and Cuba
PDS Biotechnology, Inc. Announces Appointment of Biotech Industry Leader Sir Richard Sykes to its Board of Directors as Executive Chairman
Greenspun Appointed to Expanded Role with Deloitte Center for Health Solutions
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
$12M Investment in Orphan Drug Company Nutrinia, Brings Hope to Pre-term and Short Bowel Syndrome Infants
Portage's Biohaven Receives Response from FDA to its Pre-IND Meeting Request
Pronutria Biosciences Announces Issuance of Key Patents from USPTO on Compositions and Methods Relating to Oral Biologics
New Report: Decades of Drug Research Failures and Successes Transform Hepatitis C from Incurable to Curable Disease
Published Study Shows Panorama™ NIPT Is Validated To Screen For Microdeletion Syndromes At 9 Weeks Of Pregnancy
Neogen reports 26% increase in net income
SomaGenics Receives $2,275,000 in NIH Funding to Develop its RNAi Therapeutics and microRNA Technologies
Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development
Kalorama: Market For Testing On Tissues and Cells Reaches 7.5 Billion-Dollars
HUYA Bioscience International Establishes Alliance with China Wuqing Development Area
Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer
D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA
Biorem Announces Management Change
Celator® Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
"Master Regulator" Gene -- Long Tied To Autism Disorders -- Can Stimulate Other Genes Involved In Early Brain Development
Successful FDA Inspection at Hovione
Curemark CEO Delivers Keynote Speech at Epigenetics Conference
First Patient Treated in Mapi Pharma's Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)
BIONOVA asks: Men Skincare is a necessity or a treat?
PAREXEL International Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call
Novogen Raises A$4.1m In Private Placement to US Institutions
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology
Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris
Synageva BioPharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Monday, January 12, 2015 at 9:00 a.m. PST
Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301
IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019
CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma
United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change
First European Approval for Implant Made of PEEK-OPTIMA® HA Enhanced
Cardio3 Biosciences Will be Present at ODDO Midcap Forum
Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board

< Prev Next >
PR Newswire - United Business Media